A commentary on “PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron”

• Sakthijothi Muthu,
• Sundararajan Venkatesh

Affiliations

Sakthijothi Muthu

Department of Physiology and Pharmacology School of Medicine, West Virginia University Morgantown West Virginia USA

Sundararajan Venkatesh

Department of Physiology and Pharmacology School of Medicine, West Virginia University Morgantown West Virginia USA